ClinicalTrials.Veeva

Menu

2nd International Survey on Interventional Strategies

M

Medical University of Graz

Status

Unknown

Conditions

Coronary Artery Disease

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The study aims to evaluate the decision-making pathways of interventional cardiologists, when assessing patients, presented with stable coronary artery disease.

Full description

2nd International Survey on Interventional Strategies is a web-based platform.

The survey contains specific questions and dedicated case presentations on two major topics.

The first part queries the characteristics of the participants, including overall experience in interventional cardiology, annual volume of percutaneous coronary intervention (PCI), and duration of experience with quantitative coronary angiography (QCA), intravascular ultrasound (IVUS),optical coherence tomography (OCT), fractional flow reserve (FFR) and non-hyperaemic pressure ratios (NHPR). The survey uses here predefined categories and single-choice questions.

The second part investigates personal strategies for evaluating angiographically intermediate stenoses in the catheterization laboratory. Here, participants are asked to evaluate 5 complete coronary angiograms. All cases are characterised as stable angina without relevant changes on resting ECG. No information about non-invasive testing is known or provided.

Here participants are asked to (1) localise all relevant stenoses by indicating the involved segment; (2) define percent diameter stenosis (%DS) by visual estimate; and (3) determine the significance of the stenosis of interest. In cases of angiographic uncertainty, the preferred diagnostic tool is asked to be selected from the arsenal available in the catheterisation laboratory, namely QCA, IVUS, OCT, FFR or NHPR. Participants are asked to make their decisions assuming ideal world conditions, without considering any financial restrictions or local regulations, but only after the best clinical practice achievable in this virtual catheterisation laboratory.

Enrollment

500 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Interventional cardiologists
  • Interventional cardiologists in training

Trial design

500 participants in 5 patient groups

Level of experience in interventional cardiology
Description:
Total cohort will be grouped according to experience in interventional cardiology, as defined by a single choice questionnaire: Yearly personal PCI volume Less than 75 / Between 75 and 150 / Between 151 and 250 / More than 250
Level of experience with intravascular ultrasound
Description:
Total cohort will be grouped according to experience with intravascular ultrasound, as defined by a single choice questionnaire: General: No experience / Less than 1 year / Between 1 and 3 years / Between 3 and 5 years / More than 5 years Yearly: None / Less than 15 / Between 15 and 50 / More than 50
Level of experience with optical coherence tomography
Description:
Total cohort will be grouped according to experience with optical coherence tomography, as defined by a single choice questionnaire: General: No experience / Less than 1 year / Between 1 and 3 years / Between 3 and 5 years / More than 5 years Yearly: None / Less than 15 / Between 15 and 50 / More than 50
Level of experience with fractional flow reserve
Description:
Total cohort will be grouped according to experience with fractional flow reserve, as defined by a single choice questionnaire: General: No experience / Less than 1 year / Between 1 and 3 years / Between 3 and 5 years / More than 5 years Yearly: None / Less than 50 / Between 50 and 150 / Between 151 and 250 / More than 250
Level of experience with non-hyperaemic pressure ratios
Description:
Total cohort will be grouped according to experience with non-hyperaemic pressure ratios, as defined by a single choice questionnaire: General: No experience / Less than 1 year / Between 1 and 3 years / Between 3 and 5 years / More than 5 years Yearly: None / Less than 50 / Between 50 and 150 / Between 151 and 250 / More than 250

Trial contacts and locations

0

Loading...

Central trial contact

Emanuele Barbato, MD, PhD; Gabor G Toth, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems